Cargando…
Frequency of Positive Conversion of Interferon-Gamma Release Assay Results Among Patients With Inflammatory Bowel Disease Treated With Non-tumor Necrosis Factor Inhibitors
Considering the risk of reactivation of latent tuberculosis infection (LTBI), not only before starting tumor necrosis factor inhibitors but also before non-TNF inhibitor therapy, LTBI screening is routinely recommended for patients with inflammatory bowel disease (IBD). However, data on the positive...
Autores principales: | Kim, Kyuwon, Jo, Kyung-Wook, Shim, Tae Sun, Park, Jin Hwa, Hwang, Sung Wook, Park, Sang Hyoung, Yang, Dong-Hoon, Byeon, Jeong-Sik, Myung, Seung-Jae, Yang, Suk-Kyun, Ye, Byong Duk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175966/ https://www.ncbi.nlm.nih.gov/pubmed/34095175 http://dx.doi.org/10.3389/fmed.2021.670242 |
Ejemplares similares
-
Risk and characteristics of tuberculosis after anti-tumor necrosis factor therapy for inflammatory bowel disease: a hospital-based cohort study from Korea
por: Lee, Jae Yong, et al.
Publicado: (2021) -
Incidence of Active Tuberculosis within One Year after Tumor Necrosis Factor Inhibitor Treatment according to Latent Tuberculosis Infection Status in Patients with Inflammatory Bowel Disease
por: Kang, Jieun, et al.
Publicado: (2018) -
The Clinical Features of Inflammatory Bowel Disease in Patients with Obesity
por: Kim, Seong Kyun, et al.
Publicado: (2021) -
Seroprevalence of viral infectious diseases and associated factors in Korean patients with inflammatory bowel diseases
por: Hong, Hee Seung, et al.
Publicado: (2022) -
Short-term tolerability and effectiveness of methotrexate monotherapy
in adult patients with Crohn’s disease: a retrospective study
por: Hong, Hee Seung, et al.
Publicado: (2021)